Cleared Traditional

K211269 - Visualase MRI-Guided Laser Ablation System (SW 3.4) (FDA 510(k) Clearance)

Jan 2022
Decision
255d
Days
Class 2
Risk

K211269 is an FDA 510(k) clearance for the Visualase MRI-Guided Laser Ablation System (SW 3.4). This device is classified as a Neurosurgical Laser With Mr Thermography (Class II - Special Controls, product code ONO).

Submitted by Medtronic Navigation, Inc. (Louisville, US). The FDA issued a Cleared decision on January 7, 2022, 255 days after receiving the submission on April 27, 2021.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 878.4810. Laser Device For Use To Necrotize Or Coagulate Soft Tissue Through Interstitial Irradition Or Thermal Therapy Under Mri Guidance And Real Time Mr Thermography In Neurosurgery..

Submission Details

510(k) Number K211269 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 2021
Decision Date January 07, 2022
Days to Decision 255 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code ONO — Neurosurgical Laser With Mr Thermography
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4810
Definition Laser Device For Use To Necrotize Or Coagulate Soft Tissue Through Interstitial Irradition Or Thermal Therapy Under Mri Guidance And Real Time Mr Thermography In Neurosurgery.